Abiopharma

🔍 KOEMPEL MICHAEL (Executive)

Company: SUPERIOR GROUP OF COMPANIES, INC. (SGC)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 60,500 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 139,730.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: This is a restricted stock award which vests on the third anniversary of the grant date or 05/07/2029.
• F2: On May 7, 2026, the date such restricted stock award was granted, the closing price of the issuer's common stock on the NASDAQ was $12.00 per share.
• F3: Certain of these shares were granted under restricted stock awards and are subject to forfeiture. Of such shares, 114,851 continue to be subject to forfeiture as of the date of this filing.